AAAAAA

   
Results: 1-9 |
Results: 9

Authors: HALE JJ MILLS SG MACCOSS M FINKE PE CASCIERI MA SADOWSKI S BER E CHICCHI GG KURTZ M METZGER J EIERMANN G TSOU NN TATTERSALL FD RUPNIAK NMJ WILLIAMS AR RYCROFT W HARGREAVES R MACINTYRE DE
Citation: Jj. Hale et al., STRUCTURAL OPTIMIZATION AFFORDING ENYL-4-(3-OXO-1,2,4-TRIAZOL-5-YL)METHYLMORPHOLINE, A POTENT, ORALLY-ACTIVE, LONG-ACTING MORPHOLINE ACETALHUMAN NK-1 RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 41(23), 1998, pp. 4607-4614

Authors: RUPNIAK NMJ TATTERSALL FD WILLIAMS AR RYCROFT W CARLSON EJ CASCIERI MA SADOWSKI S BER E HALE JJ MILLS SG MACCOSS M SEWARD E HUSCROFT I OWEN S SWAIN CJ HILL RG HARGREAVES RJ
Citation: Nmj. Rupniak et al., IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS, European journal of pharmacology, 326(2-3), 1997, pp. 201-209

Authors: RUPNIAK NMJ TATTERSALL FD WILLIAMS AR RYCROFT W CARLSON EJ CASCIERI MA HALE JJ MILLS SG MACCOSS M SEWARD E HUSCROFT I SWAIN CJ HILL RG HARGREAVES RJ
Citation: Nmj. Rupniak et al., PREDICTION OF THE ANTIEMETIC ACTIVITY OF NK1 RECEPTOR ANTAGONISTS IN FERRETS BY THEIR ABILITY TO INHIBIT GR73632-INDUCED FOOT TAPPING IN GERBILS, British Journal of Pharmacology, 120, 1997, pp. 363-363

Authors: TATTERSALL FD RYCROFT W FRANCIS B PEARCE D MERCHANT K MACLEOD AM LADDUWAHETTY T KEOWN L SWAIN C BAKER R CASCIERI M BER E METZGER J MACINTYRE DE HILL RG HARGREAVES RJ
Citation: Fd. Tattersall et al., TACHYKININ NK1 RECEPTOR ANTAGONISTS ACT CENTRALLY TO INHIBIT EMESIS INDUCED BY THE CHEMOTHERAPEUTIC AGENT CISPLATIN IN FERRETS, Neuropharmacology, 35(8), 1996, pp. 1121-1129

Authors: LADDUWAHETTY T BAKER R CASCIERI MA CHAMBERS MS HAWORTH K KEOWN LE MACINTYRE DE METZGER JM OWEN S RYCROFT W SADOWSKI S SEWARD EM SHEPHEARD SL SWAIN CJ TATTERSALL FD WATT AP WILLIAMSON DW HARGREAVES RJ
Citation: T. Ladduwahetty et al., N-HETEROARYL-2-PHENYL-3-(BENZYLOXY)PIPERIDINES - A NOVEL CLASS OF POTENT ORALLY-ACTIVE HUMAN NK1 ANTAGONISTS, Journal of medicinal chemistry, 39(15), 1996, pp. 2907-2914

Authors: TATTERSALL FD RYCROFT W MARMONT N CASCIERI M HILL RG HARGREAVES RJ
Citation: Fd. Tattersall et al., ENANTIOSPECIFIC INHIBITION OF EMESIS INDUCED BY NICOTINE IN THE HOUSEMUSK SHREW (SUNCUS-MURINUS) BY THE NEUROKININ(1) (NK1) RECEPTOR ANTAGONIST CP-99,994, Neuropharmacology, 34(12), 1995, pp. 1697-1699

Authors: JACKSON A TATTERSALL D BENTLEY G RYCROFT W BOURSON A HARGREAVES R TRICKLEBANK M IVERSEN S
Citation: A. Jackson et al., AN INVESTIGATION INTO THE DISCRIMINATIVE STIMULUS AND REINFORCING PROPERTIES OF THE CCKB-RECEPTOR ANTAGONIST, L-365,260 IN RATS, Neuropeptides, 26(5), 1994, pp. 343-353

Authors: TATTERSALL FD RYCROFT W HILL RG HARGREAVES RJ
Citation: Fd. Tattersall et al., ENANTIOSELECTIVE INHIBITION OF APOMORPHINE-INDUCED EMESIS IN THE FERRET BY THE NEUROKININ(1) RECEPTOR ANTAGONIST CP-99,994, Neuropharmacology, 33(2), 1994, pp. 259-260

Authors: TATTERSALL FD RYCROFT W HARGREAVES RJ HILL RG
Citation: Fd. Tattersall et al., THE TACHYKININ NK(1) RECEPTOR ANTAGONIST CP-99,994 ATTENUATES CISPLATIN-INDUCED EMESIS IN THE FERRET, European journal of pharmacology, 250(1), 1993, pp. 180000005-180000006
Risultati: 1-9 |